Drug Makers Face Lawsuits Against Carcinogen Drugs.

Reading Time: 2 minutes

Drug companies are now facing lawsuits against them and the sellers over generic heart medications that may contain carcinogens. 

Millions of Americans have taken generic heart medication drugs which are at the border of a scandal to recall them, they were not properly studied for decades by the U.S. Food and Drug Administration.

Approximately 50 lawsuits are at the hands of an attorney who told a U.S. federal court he expects a surge of legal action.  He also has more than 27 patients/plaintiffs who are accusing the drug makers of contracting cancer.

Attorney Daniel Nigh fiord 12 lawsuits so far, and he has told the judges in a US District Court in NJ, according to a transcript: “My best estimate sitting here today is I expect that we will have approximately 2,000 personal-injury cases on file in the next two years”. 


The FDA has been working on recalling such heart medications since July 2018 and mentioned that the pills might have been contaminated with NDMA for as long as four years before the problem was found.


Valsartan has been contaminated by a carcinogen NDMA manufactured by Zhejiang Huahai  Pharmaceuticals, which is also targeted in the lawsuits. This was sold to major drug companies and has been used as an ingredient in other popular cardiovascular therapies.  Amongst them, there are more drug makers in the complaints, such as generic Teva Pharmaceutical Industries Ltd. and Mylan NV, as well as CVS Health Corp.

Over 30 defendants are involved in the lawsuit as shares of Zhejiang Huahai lost approximately 2.5 percent on Wednesday in China.


 In 2018 alone, 1.5 million people in the United States took contaminated Valsartan.

Senior U.S. District Judge Robert Kugler told the lawyers at the March 2019 meeting that proving that these drugs caused cancer to the plaintiffs may be a challenge: “There’s a number of people who claim, I understand, that they’ve contracted cancer from taking this drug, it’s probably going to be a heavy lift to prove that, but you know, we’ll see what happens.”

At Baker Street Funding, we give you the inside scoop on pre-settlement funding by covering a variety of ... financing and legal topics to help you made the best financial decision for you and for your case. Our experts break down complex ideas in a way that's easy to understand so you can stay informed on current trends as well as tips and fact checked information by the CEO and founder, Daniel Digiaimo. Furthermore, Despite its name, consumer legal funding is not a loan. If you don't win your case, no payment needs to be made back. To avoid confusion and simplify matters on, we'll use the word "loan" throughout this article.

About Baker Street Funding

Baker Street Legal Funding helps plaintiffs and attorneys achieve financial ease during litigation through our non-recourse funding products. Our services give out thousands of clients fast access to tools and transparent information so you can get the needed funds with competitive rates. Baker Street Funding approval methods come with critical essentials for getting ahead fast, including larger approvals in connection to a thriving funding team of like-minded people. 

For more information, visit bakerstreetfunding.com/about/

* This post is for educational and informational purposes only. Please consult your attorney and your financial and tax advisors before making any decisions. Terms and conditions can be found at bakerstreetfunding.com/privacy-policy

Select a legal funding service to get started. 

Attorney Requests

Lawsuit Loans

Litigation Funding

Personal Injury Loans

Settled Case Loans

Surgery Funding

Or just call us at 888.711.3599 to apply.